# Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+

> **NCT01220076** · PHASE2 · COMPLETED · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 140 (actual)

## Conditions studied

- Non Metastatic Breast Cancer

## Interventions

- **DRUG:** tamoxifen

## Key facts

- **NCT ID:** NCT01220076
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2021-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01220076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01220076, "Biological Response to Tamoxifen (TAM) in Patients With Breast Cancer Non Metastatic RH+". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01220076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*